NCT06656351View on ClinicalTrials.gov

B-FREE Chronic Babesiosis Study

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

September 30, 2027

Conditions
Chronic Babesiosis
Interventions
DRUG

Tafenoquine 100mg

Tafenoquine

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

Sponsors
All Listed Sponsors
lead

60 Degrees Pharmaceuticals LLC

INDUSTRY